Robert Lechleider
Patrimonio netto: 2 M $ in data 30/09/2026
Patrimonio netto: 2 M $ in data 30/09/2026
Robert Lechleider is currently Chief Medical Officer at Immunome, Inc. since 2023.
Formerly, Dr. Lechleider was Chief Medical Officer at OncoResponse, Inc. from 2020 to 2023 and Senior Vice President-Clinical Development at Seagen, Inc. from 2016 to 2020.
Education includes undergraduate studies at Princeton University and a doctorate from the University of Illinois College of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
IMMUNOME, INC. 0,06% | 23/07/2026 | 69.805 ( 0,06% ) | 2 M $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNOME, INC. | Direttore Tecnico/Scientifico/R&S | 19/10/2023 |
| Società | Posizione | Fine |
|---|---|---|
OncoResponse, Inc.
OncoResponse, Inc. Pharmaceuticals: MajorHealth Technology Discovers cancer immunotherapies by interrogating the human immune system | Direttore Tecnico/Scientifico/R&S | 01/10/2023 |
| SEAGEN INC. | Direttore Tecnico/Scientifico/R&S | 01/04/2020 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Immunome, Inc.
Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois College of Medicine
University of Illinois College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoResponse, Inc.
OncoResponse, Inc. Pharmaceuticals: MajorHealth Technology Discovers cancer immunotherapies by interrogating the human immune system | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale